Neuroendocrine tumors originate from neuroendocrine cells, often presenting as slower-growing compared to other cancers like ...

Patients with diabetes have high blood glucose levels either because their pancreas does not produce sufficient insulin, or their body cells do not respond to signals from insulin that tell them to ...

Pancreatic neuroendocrine tumors (PanNETs) represent a heterogeneous group of rare neoplasms that arise in the endocrine tissues of the pancreas. In general, although current nomenclature classifies ...

Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes. This has been shown by a study conducted at, among others, the ...

If you or a loved one has gastroenteropancreatic neuroendocrine tumors (GEP-NETs), you may be interested in learning about treatment options. One medicine you might hear about is Lutathera (lutetium ...

The Somatostatin Analogs Market growth is driven by rising cases of NETs, acromegaly, and Cushing’s disease along with strong R&D investment.Austin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Somatostatin ...

Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes. The proposed strategy is said to have the potential to save lives.

New findings raise the possibility of promising therapeutic strategies for the management of hypoglycemia in type 1 diabetes patients. Study: Loss of electrical β-cell to δ-cell coupling underlies ...

Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes. This has been shown by a study conducted at, among others, the ...